1. Home
  2. NAKA vs ABEO Comparison

NAKA vs ABEO Comparison

Compare NAKA & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kindly MD Inc.

NAKA

Kindly MD Inc.

HOLD

Current Price

$0.38

Market Cap

265.2M

Sector

N/A

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.17

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAKA
ABEO
Founded
2019
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.2M
281.0M
IPO Year
2024
1980

Fundamental Metrics

Financial Performance
Metric
NAKA
ABEO
Price
$0.38
$5.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$4.50
$18.20
AVG Volume (30 Days)
7.0M
1.2M
Earning Date
11-19-2025
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
$1,980,278.00
$400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,517.33
$1,589.77
P/E Ratio
N/A
$4.03
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$3.93
52 Week High
$34.77
$7.54

Technical Indicators

Market Signals
Indicator
NAKA
ABEO
Relative Strength Index (RSI) 38.19 49.78
Support Level $0.39 $5.05
Resistance Level $0.44 $5.41
Average True Range (ATR) 0.04 0.24
MACD 0.00 -0.01
Stochastic Oscillator 2.96 29.33

Price Performance

Historical Comparison
NAKA
ABEO

About NAKA Kindly MD Inc.

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: